Life Sciences News | BioTuesdays by Kilmer Lucas IR

Developments

Leonard Wheeler, former NFL player, named global ambassador for Profound’s TULSA-PRO

Profound Medical (NASDAQ: PROF; TSX: PRN) today announced that it has entered into a consulting agreement with Leonard Wheeler—former NFL player, entrepreneur, author, corporate consultant, co-executive director of the...

June 4, 2025

Executive Moves

Dyadic announces leadership change as part of strategic shift

Dyadic International (NASDAQ: DYAI) announced that its board of directors has appointed Joe Hazelton as president, effective immediately, as part of an ongoing strategic shift to evolve into a revenue-generating...

June 2, 2025

Developments

Defence opens first U.S. laboratory

Defence Therapeutics (CSE: DTC; OTCQB: DTCFF; FSE: DTC) announced that it has opened its first U.S.-based laboratory in the Boston-Cambridge area. According to Defence, the new laboratory will allow the company to...

June 2, 2025

Developments

atai and Beckley to combine establishing market leader in psychedelic mental health therapies

atai Life Sciences (NASDAQ: ATAI) and closely held Beckley Psytech announced a definitive agreement to combine in an all-share transaction subject to Phase 2b success criteria of BPl-003 in patients with treatment...

June 2, 2025

Developments

Genflow and CER agree to long-term R&D collaboration

Genflow Biosciences (LSE:GENF; OTCQB:GENFF) has announced the signing of a master service agreement (MSA) with closely held CER Groupe—a long-standing partner—to strengthen long-term research and development (R&D)...

May 28, 2025

Executive Moves

enGene appoints Amy Pott as chief global commercialization officer

enGene Holdings (NASDAQ: ENGN) announced the appointment of Amy Pott as chief global commercialization officer—the company’s first dedicated executive for commercialization endeavors—reporting to Ron Cooper, CEO of...

May 28, 2025

Developments

NeoGenomics introduces PanTracer genomic profiling tests at ASCO 2025

NeoGenomics (NASDAQ: NEO) has announced that it will debut its PanTracer Family genomic profiling tests for advanced solid tumors at the 2025 American Society of Clinical Oncology (ASCO) in Chicago May 30—June 3, 2025...

May 28, 2025

Executive Moves

CellCentric appoints Celia Economides as CFO & CBO

Closely held CellCentric has announced that it is expanding its leadership team with the appointment of Celia Economides as Chief Financial Officer & Chief Business Officer (CFO & CBO). According...

May 27, 2025

Executive Moves

Accomplished medtech industry veteran, Laurie Vertuccio, joins Profound Medical as VP of Global Marketing

Laurie Vertuccio has joined Profound Medical (NASDAQ:PROF; TSX:PRN) as Vice President of Global Marketing. The TULSA procedure, performed using Profound’s TULSA-PRO system, has the potential of becoming a mainstream...

May 27, 2025

Developments

Perimeter partners with Intermountain Health to study benefits of using OCT and AI to reduce cancer reoperations

Perimeter Medical Imaging AI (TSXV: PINK; OTCQX: PYNKF) has announced that it has entered into a development support agreement with Intermountain Health, creating the framework for the two organizations to partner on a...

May 23, 2025

Executive Moves

Scienture announces executive leadership transition

Scienture Holdings (NASDAQ: SCNX) announced that Suren Ajjarapu, CEO and chairman of the board, has stepped down. The management team of Dr. Shankar Hariharan and Dr. Narasimhan Mani will assume these roles. Shankar...

May 22, 2025

Developments

FDA clears Quoin’s second QRX003 NS pivotal study

Quoin Pharmaceuticals (NASDAQ: QNRX) announced that the FDA has provided clearance to initiate a second Netherton Syndrome (NS) clinical pivotal study—CL-QRX003-002, for Quoin’s lead product QRX003. According to Quoin...

May 22, 2025

Subscribe